The
Report Global Monoclonal Antibodies Market 2016-2020 provides
information on pricing, market analysis, shares, forecast, and
company profiles for key industry participants. -
MarketResearchReports.biz"
About Monoclonal Antibodies
Antibodies
are the proteins produced by B-cells (in the bone marrow) in the
immune system. These proteins attach themselves to antigens, which
act as markers, and are then destroyed by phagocytes. B-cells produce
different antibodies, which attach themselves to different sites of
an antigen. mAbs are monospecific, as they are the clones of a single
parent cell. They are complex proteins with high molecular weight,
and were first developed in 1975 by Kohler and Milstein.
Technavios
analysts forecast the global monoclonal antibodies (mAbs) market to
grow at a CAGR of 9.84% during the period 2016-2020.
View Report At
:http://www.marketresearchreports.biz/analysis/768108
Covered in this report
The
report covers the present scenario and the growth prospects of the
global monoclonal antibodies (mAbs) market for 2016-2020. To
calculate the market size, the report considers the revenue generated
from the sales of branded mAbs and biosimilars used to treat cancer,
autoimmune and inflammatory diseases, respiratory diseases, and
ophthalmology. It also considers the revenues to be generated from
the sales of drugs that are expected to be launched into the market,
along with the decline in revenues from the patent expiries of the
marketed drugs, during the forecast period.
The market is divided into
the following segments based on geography:
Americas
APAC
EMEA
Technavio's
report, Global Monoclonal Antibodies (mAbs) Market 2016-2020, has
been prepared based on an in-depth market analysis with inputs from
industry experts. The report covers the market landscape and its
growth prospects over the coming years. The report also includes a
discussion of the key vendors operating in this market.
Download
Sample copy of this Report at:
http://www.marketresearchreports.biz/sample/sample/768108
Key vendors
AbbVie
Amgen
Bristol-Myers
Squibb
F.
Hoffmann-La Roche
Johnson
& Johnson
Merck
Other prominent vendors
AbGenomics
ADC
Therapeutics
Agensys
Alexion
Pharmaceuticals
ALMAC
Group
Ambrx
Astellas
Pharma
Human
Genome Sciences
Immunogen
MedImmune
Novartis
Pfizer
Seattle
Genetics
Stemcentrx
Teva
UCB
Market driver
Special
regulatory drug designations
For
a full, detailed list, view our report
Market challenge
High
manufacturing costs coupled with stringent regulations
For
a full, detailed list, view our report
Market trend
Growing
focus of vendors on untapped markets
For
a full, detailed list, view our report
Key questions answered in
this report
What
will the market size be in 2020 and what will the growth rate be?
What
are the key market trends?
What
is driving this market?
What
are the challenges to market growth?
Who
are the key vendors in this market space?
What
are the market opportunities and threats faced by the key vendors?
What
are the strengths and weaknesses of the key vendors?
Follow
us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
Table
Of Content
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Assumptions
Top-vendor offerings
PART 03: Market research
methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: mAbs: Overview
Evolution of mAb therapeutics
Types of mAbs
Conjugated cancer therapies
using mAbs
PART 06: Market landscape
Market overview
Five forces analysis
PART 07: Market segmentation by
type of mAbs
Naked mAbs
Conjugated mAbs
PART 08: Market segmentation by
application
Global oncology mAbs market
Global autoimmune and
inflammatory mAbs market
TNF inhibitors
IL-1 blockers
PDE4 inhibitors
Global respiratory mAbs market
Global ophthalmology mAbs
market
PART 09: Geographical
segmentation
Global mAbs market by
geographical segmentation 2015-2020
mAbs market in Americas
mAbs market in US
mAbs market in EMEA
mAbs market in APAC
PART 10: Key leading countries
PART 11: Pipeline portfolio
PART 12: Market drivers
Reimbursement benefits for mAbs
and its biosimilars
Special regulatory drug
designations
Increase in demand for ADCs
Increase in industry-academia
collaborations
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment